[
    {
        "title": "Revolutionizing Drug Development Through Artificial Intelligence ... - Pharmacy Times",
        "description": "Revolutionizing Drug Development Through Artificial Intelligence ...  Pharmacy Times",
        "published date": "Thu, 31 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvcmV2b2x1dGlvbml6aW5nLWRydWctZGV2ZWxvcG1lbnQtdGhyb3VnaC1hcnRpZmljaWFsLWludGVsbGlnZW5jZS1tYWNoaW5lLWxlYXJuaW5n0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Empagliflozin is associated with lower cardiovascular risk compared ... - Cardiovascular Diabetology",
        "description": "Empagliflozin is associated with lower cardiovascular risk compared ...  Cardiovascular Diabetology",
        "published date": "Thu, 31 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vY2FyZGlhYi5iaW9tZWRjZW50cmFsLmNvbS9hcnRpY2xlcy8xMC4xMTg2L3MxMjkzMy0wMjMtMDE5NjMtOdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Dihydromyricetin on the pharmacokinetics of flconazole | DDDT - Dove Medical Press",
        "description": "Dihydromyricetin on the pharmacokinetics of flconazole | DDDT  Dove Medical Press",
        "published date": "Thu, 31 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5kb3ZlcHJlc3MuY29tL3RoZS1lZmZlY3Qtb2YtZGloeWRyb215cmljZXRpbi1vbi10aGUtcGhhcm1hY29raW5ldGljcy1vZi1mbHVjb25hem9sZS0tcGVlci1yZXZpZXdlZC1mdWxsdGV4dC1hcnRpY2xlLURERFTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]